Header Logo

Connection

FREDERICK LANG to Brain Neoplasms

Back to Details
This is a "connection" page, showing publications FREDERICK LANG has written about Brain Neoplasms.
FREDERICK LANG
Connection Strength
7.474
Brain Neoplasms
  1. Facilitating Repeat Intracarotid Injections in Mouse Models by a Novel Injection Site Repair Technique. J Vis Exp. 2024 Mar 15; (205).
    View in: PubMed
    Score: 0.291
  2. Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma. Neuro Oncol. 2024 02 02; 26(2):236-250.
    View in: PubMed
    Score: 0.289
  3. Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics. Neuro Oncol. 2024 01 05; 26(1):127-136.
    View in: PubMed
    Score: 0.287
  4. Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors. Neurosurg Clin N Am. 2021 Jan; 32(1):93-104.
    View in: PubMed
    Score: 0.231
  5. Stem Cell Therapy of Gliomas. Prog Neurol Surg. 2018; 32:124-151.
    View in: PubMed
    Score: 0.196
  6. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427.
    View in: PubMed
    Score: 0.191
  7. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017 05 01; 19(5):660-668.
    View in: PubMed
    Score: 0.181
  8. Ionizing radiation augments glioma tropism of mesenchymal stem cells. J Neurosurg. 2018 01; 128(1):287-295.
    View in: PubMed
    Score: 0.180
  9. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas. Cytotherapy. 2017 04; 19(4):445-457.
    View in: PubMed
    Score: 0.178
  10. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg. 2013 Apr; 118(4):873-883.
    View in: PubMed
    Score: 0.135
  11. Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens. Childs Nerv Syst. 2013 Apr; 29(4):549-63.
    View in: PubMed
    Score: 0.134
  12. Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation. Childs Nerv Syst. 2013 Jan; 29(1):55-64.
    View in: PubMed
    Score: 0.133
  13. Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Childs Nerv Syst. 2013 Feb; 29(2):217-29.
    View in: PubMed
    Score: 0.133
  14. Glioblastoma resection. J Neurosurg. 2012 May; 116(5):1166-7; author reply 1167-8.
    View in: PubMed
    Score: 0.126
  15. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia. 2011 Aug; 13(8):716-25.
    View in: PubMed
    Score: 0.121
  16. Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst. 2011 Jun; 27(6):911-22.
    View in: PubMed
    Score: 0.117
  17. Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases. Neuro Oncol. 2010 Jul; 12(7):711-9.
    View in: PubMed
    Score: 0.110
  18. High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors. J Neurooncol. 2010 Aug; 99(1):57-64.
    View in: PubMed
    Score: 0.109
  19. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009 Dec 01; 69(23):8932-40.
    View in: PubMed
    Score: 0.108
  20. Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes. J Neurooncol. 2009 May; 92(3):357-71.
    View in: PubMed
    Score: 0.103
  21. Clinical problem-solving: island intruder. Neurosurgery. 2008 Apr; 62(4):920-8; discussion 928-9.
    View in: PubMed
    Score: 0.096
  22. Management of patients with low-grade gliomas. Neurol Clin. 2007 Nov; 25(4):1073-88, ix.
    View in: PubMed
    Score: 0.094
  23. Anaplastic oligodendroglial tumors: a tale of two trials. J Clin Oncol. 2006 Jun 20; 24(18):2689-90.
    View in: PubMed
    Score: 0.085
  24. Surgical resection of intrinsic insular tumors. Neurosurgery. 2005 Jul; 57(1 Suppl):176-83; discussion 176-83.
    View in: PubMed
    Score: 0.080
  25. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005 Apr 15; 65(8):3307-18.
    View in: PubMed
    Score: 0.078
  26. Prospective clinical trials of brain tumor therapy: the critical role of neurosurgeons. J Neurooncol. 2004 Aug-Sep; 69(1-3):151-67.
    View in: PubMed
    Score: 0.075
  27. Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice. Mol Ther. 2024 Mar 06; 32(3):722-733.
    View in: PubMed
    Score: 0.072
  28. The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19; 12(1):13.
    View in: PubMed
    Score: 0.072
  29. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses. J Neurooncol. 2003 Dec; 65(3):237-46.
    View in: PubMed
    Score: 0.071
  30. Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance. Sci Adv. 2023 08 04; 9(31):eadf3984.
    View in: PubMed
    Score: 0.070
  31. Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro Oncol. 2023 Jul 06; 25(7):1310-1320.
    View in: PubMed
    Score: 0.069
  32. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18.
    View in: PubMed
    Score: 0.069
  33. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60.
    View in: PubMed
    Score: 0.069
  34. Current surgical management of glioblastoma. Cancer J. 2003 Mar-Apr; 9(2):113-25.
    View in: PubMed
    Score: 0.068
  35. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin. 2022 09; 72(5):454-489.
    View in: PubMed
    Score: 0.064
  36. Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. Clin Cancer Res. 2022 05 02; 28(9):1979-1990.
    View in: PubMed
    Score: 0.064
  37. Preclinical animal brain tumor models for interventional neuro-oncology. J Neurointerv Surg. 2022 05; 14(5).
    View in: PubMed
    Score: 0.064
  38. A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-8.
    View in: PubMed
    Score: 0.064
  39. Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors. J Neurointerv Surg. 2022 Jun; 14(6):533-538.
    View in: PubMed
    Score: 0.062
  40. Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 2021 10 01; 10(10).
    View in: PubMed
    Score: 0.061
  41. Hitchhiking to brain tumours: stem cell delivery of oncolytic viruses. Lancet Oncol. 2021 08; 22(8):1049-1051.
    View in: PubMed
    Score: 0.060
  42. Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment. Oncogene. 2020 12; 39(50):7253-7264.
    View in: PubMed
    Score: 0.057
  43. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight. 2020 09 03; 5(17).
    View in: PubMed
    Score: 0.057
  44. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging. 2020 Jul 11; 20(1):47.
    View in: PubMed
    Score: 0.056
  45. Language supplementary motor area syndrome correlated with dynamic changes in perioperative task-based functional MRI activations: case report. J Neurosurg. 2020 06 05; 134(6):1738-1742.
    View in: PubMed
    Score: 0.056
  46. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery. 2020 01 01; 86(1):112-121.
    View in: PubMed
    Score: 0.054
  47. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. J Neurointerv Surg. 2020 Feb; 12(2):197-203.
    View in: PubMed
    Score: 0.054
  48. Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas. Clin Cancer Res. 2019 11 15; 25(22):6801-6814.
    View in: PubMed
    Score: 0.053
  49. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 06 10; 21(6):775-785.
    View in: PubMed
    Score: 0.052
  50. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 12 01; 129(6):1446-1455.
    View in: PubMed
    Score: 0.050
  51. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 12 15; 24(24):6288-6299.
    View in: PubMed
    Score: 0.049
  52. Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a. Sci Rep. 2018 05 29; 8(1):8267.
    View in: PubMed
    Score: 0.049
  53. Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection. Nanotechnology. 2018 Apr 20; 29(16):165101.
    View in: PubMed
    Score: 0.048
  54. Large Scale Identification of Variant Proteins in Glioma Stem Cells. ACS Chem Neurosci. 2018 01 17; 9(1):73-79.
    View in: PubMed
    Score: 0.047
  55. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol. 2017 Oct 19; 19(11):1494-1502.
    View in: PubMed
    Score: 0.047
  56. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1040-1048.
    View in: PubMed
    Score: 0.046
  57. Interrogating IDH Mutation in Brain Tumor: Magnetic Resonance and Hyperpolarization. Top Magn Reson Imaging. 2017 Feb; 26(1):27-32.
    View in: PubMed
    Score: 0.044
  58. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol. 2017 Jan; 29(1):46-58.
    View in: PubMed
    Score: 0.044
  59. Interrogating Metabolism in Brain Cancer. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):687-703.
    View in: PubMed
    Score: 0.044
  60. The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma. Mol Cancer Res. 2016 12; 14(12):1277-1287.
    View in: PubMed
    Score: 0.043
  61. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas. Oncotarget. 2016 Mar 29; 7(13):16146-57.
    View in: PubMed
    Score: 0.042
  62. Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51. Neuro Oncol. 2016 08; 18(8):1109-19.
    View in: PubMed
    Score: 0.042
  63. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112.
    View in: PubMed
    Score: 0.041
  64. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting. Oncotarget. 2015 Oct 13; 6(31):31007-17.
    View in: PubMed
    Score: 0.041
  65. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol. 2015 Oct; 130(4):587-97.
    View in: PubMed
    Score: 0.040
  66. Dose painting with Gamma Knife: Two techniques for delivering different doses to areas of recurrent or residual tumor after resection of brain metastases. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):390-7.
    View in: PubMed
    Score: 0.040
  67. ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts. J Proteome Res. 2015 Jun 05; 14(6):2511-9.
    View in: PubMed
    Score: 0.039
  68. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol. 2015 Nov; 17(11):1463-73.
    View in: PubMed
    Score: 0.039
  69. Systematic identification of single amino acid variants in glioma stem-cell-derived chromosome 19 proteins. J Proteome Res. 2015 Feb 06; 14(2):778-86.
    View in: PubMed
    Score: 0.038
  70. Impact of preoperative functional magnetic resonance imaging during awake craniotomy procedures for intraoperative guidance and complication avoidance. Stereotact Funct Neurosurg. 2014; 92(5):315-22.
    View in: PubMed
    Score: 0.038
  71. Awake craniotomy for gliomas in a high-field intraoperative magnetic resonance imaging suite: analysis of 42 cases. J Neurosurg. 2014 Oct; 121(4):810-7.
    View in: PubMed
    Score: 0.037
  72. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8).
    View in: PubMed
    Score: 0.037
  73. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628.
    View in: PubMed
    Score: 0.037
  74. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol. 2014 Mar 10; 32(8):774-82.
    View in: PubMed
    Score: 0.036
  75. A high Notch pathway activation predicts response to ? secretase inhibitors in proneural subtype of glioma tumor-initiating cells. Stem Cells. 2014 Jan; 32(1):301-12.
    View in: PubMed
    Score: 0.036
  76. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol. 2014 Jan; 16(1):81-91.
    View in: PubMed
    Score: 0.036
  77. Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. J Proteome Res. 2014 Jan 03; 13(1):191-9.
    View in: PubMed
    Score: 0.036
  78. Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis. J Neurooncol. 2013 Dec; 115(3):513-20.
    View in: PubMed
    Score: 0.035
  79. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26.
    View in: PubMed
    Score: 0.034
  80. Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells. Cancer Res. 2013 May 15; 73(10):3062-74.
    View in: PubMed
    Score: 0.034
  81. TGF-? mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. Cancer Res. 2013 Apr 01; 73(7):2333-44.
    View in: PubMed
    Score: 0.034
  82. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013 Feb; 123(2):855-65.
    View in: PubMed
    Score: 0.034
  83. av?8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell. 2013 Feb; 24(4):474-82.
    View in: PubMed
    Score: 0.033
  84. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011 Dec 15; 25(24):2594-609.
    View in: PubMed
    Score: 0.031
  85. Neurocognitive function before and after surgery for insular gliomas. J Neurosurg. 2011 Dec; 115(6):1115-25.
    View in: PubMed
    Score: 0.031
  86. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by ?8 integrin. Cancer Res. 2011 Oct 15; 71(20):6371-81.
    View in: PubMed
    Score: 0.030
  87. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73.
    View in: PubMed
    Score: 0.029
  88. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg. 2011 Mar; 114(3):576-84.
    View in: PubMed
    Score: 0.028
  89. Factors influencing the risk of local recurrence after resection of a single brain metastasis. J Neurosurg. 2010 Aug; 113(2):181-9.
    View in: PubMed
    Score: 0.028
  90. Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas. J Comput Assist Tomogr. 2010 Jul; 34(4):601-11.
    View in: PubMed
    Score: 0.028
  91. Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res. 2010 Jan 15; 16(2):461-73.
    View in: PubMed
    Score: 0.027
  92. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009 Nov; 10(11):1037-44.
    View in: PubMed
    Score: 0.027
  93. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther. 2009 Oct; 9(5):422-7.
    View in: PubMed
    Score: 0.027
  94. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg. 2009 Sep; 111(3):439-48.
    View in: PubMed
    Score: 0.027
  95. Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients. Neurosurgery. 2009 May; 64(5):836-45; discussion 345-6.
    View in: PubMed
    Score: 0.026
  96. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res. 2009 Apr; 7(4):489-97.
    View in: PubMed
    Score: 0.026
  97. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery. 2007 Nov; 61(5):1031-7; discussion 1037-8.
    View in: PubMed
    Score: 0.023
  98. Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev. 2008 Jan; 31(1):1-8; discussion 8-9.
    View in: PubMed
    Score: 0.023
  99. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
    View in: PubMed
    Score: 0.023
  100. Papillary tumors of the pineal region: case report. Neurosurgery. 2007 May; 60(5):E953-5; discussion E953-5.
    View in: PubMed
    Score: 0.023
  101. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007 Feb; 60(2):277-83; discussion 283-4.
    View in: PubMed
    Score: 0.022
  102. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst. 2006 May 03; 98(9):625-36.
    View in: PubMed
    Score: 0.021
  103. Oncolytic adenoviruses as antiglioma agents. Expert Rev Anticancer Ther. 2006 May; 6(5):697-708.
    View in: PubMed
    Score: 0.021
  104. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28.
    View in: PubMed
    Score: 0.021
  105. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 2006 Apr 01; 66(7):3593-602.
    View in: PubMed
    Score: 0.021
  106. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clin Cancer Res. 2006 Jan 15; 12(2):556-62.
    View in: PubMed
    Score: 0.021
  107. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol Cancer Ther. 2005 Mar; 4(3):343-9.
    View in: PubMed
    Score: 0.019
  108. Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg. 2005 Feb; 102(2):209-15.
    View in: PubMed
    Score: 0.019
  109. Brain metastases. Curr Probl Surg. 2004 Aug; 41(8):665-741.
    View in: PubMed
    Score: 0.019
  110. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1097-106.
    View in: PubMed
    Score: 0.019
  111. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas. Int J Oncol. 2004 Feb; 24(2):409-17.
    View in: PubMed
    Score: 0.018
  112. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol. 2004 Feb; 66(3):313-25.
    View in: PubMed
    Score: 0.018
  113. Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg. 2004 Jan; 100(1):61-7.
    View in: PubMed
    Score: 0.018
  114. The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery. 2003 Aug; 53(2):272-80; discussion 280-1.
    View in: PubMed
    Score: 0.017
  115. Visual-spatial neglect in a child following sub-cortical tumor resection. Dev Med Child Neurol. 2002 Mar; 44(3):191-9.
    View in: PubMed
    Score: 0.016
  116. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022 02 09; 13(1):767.
    View in: PubMed
    Score: 0.016
  117. PTV margin determination in conformal SRT of intracranial lesions. J Appl Clin Med Phys. 2002; 3(3):176-89.
    View in: PubMed
    Score: 0.016
  118. MRI venous architecture of insula. J Neurol Sci. 2018 07 15; 390:156-161.
    View in: PubMed
    Score: 0.012
  119. Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. Oncotarget. 2016 May 24; 7(21):30626-41.
    View in: PubMed
    Score: 0.011
  120. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13970-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.